'Personalized medicine' reads DNA for effective treatments
New York Times, December 30, 2008
Experts say that most drugs, whatever the disease, work for only about half the people who take them. Not only is much of the nation's approximately $300 billion annual drug spending wasted, but countless patients are being exposed unnecessarily to side effects. No wonder so much hope is riding on the promise of "personalized medicine," in which genetic screening and other tests give doctors more evidence for tailoring treatments to patients, potentially improving care and saving money.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- How Chargemaster Data May Affect Hospital Revenue
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- Building a Better Healthcare Board
- Hospital Pricing Irks Nurses; More Jobs, Less Pay
- ED Physicians Key to Half of Hospital Admissions
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Quiet ORs Better for Patient Safety
- CMS Releases Hospital Pricing Data
